Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

850 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T, Hatae M, Kodama S, Saito T, Terakawa N, Yaegashi N, Hiura M, Sakamoto A, Tsuda H, Fukunaga M, Kamura T. Ushijima K, et al. Among authors: yaegashi n. J Clin Oncol. 2007 Jul 1;25(19):2798-803. doi: 10.1200/JCO.2006.08.8344. J Clin Oncol. 2007. PMID: 17602085 Clinical Trial.
Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection.
Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, Yamaguchi S, Ochiai K, Takano M, Yokota H, Kawakami Y, Nishimura S, Ogishima D, Nakagawa S, Kobayashi H, Shiozawa T, Nakanishi T, Kamura T, Konishi I, Yoshikawa H. Satoh T, et al. Among authors: yaegashi n. J Clin Oncol. 2010 Apr 1;28(10):1727-32. doi: 10.1200/JCO.2009.24.8617. Epub 2010 Mar 1. J Clin Oncol. 2010. PMID: 20194858
Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.
Nagase S, Inoue Y, Umesaki N, Aoki D, Ueda M, Sakamoto H, Kobayashi S, Kitagawa R, Toita T, Nagao S, Hasegawa K, Fukasawa I, Fujiwara K, Watanabe Y, Ito K, Niikura H, Iwasaka T, Ochiai K, Katabuchi H, Kamura T, Konishi I, Sakuragi N, Tanaka T, Hirai Y, Hiramatsu Y, Mukai M, Yoshikawa H, Takano T, Yoshinaga K, Otsuki T, Sakuma M, Inaba N, Udagawa Y, Yaegashi N; Japan Society of Gynecologic Oncology. Nagase S, et al. Among authors: yaegashi n. Int J Clin Oncol. 2010 Apr;15(2):117-24. doi: 10.1007/s10147-010-0061-x. Epub 2010 Mar 24. Int J Clin Oncol. 2010. PMID: 20333431
Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).
Nomura H, Aoki D, Takahashi F, Katsumata N, Watanabe Y, Konishi I, Jobo T, Hatae M, Hiura M, Yaegashi N. Nomura H, et al. Among authors: yaegashi n. Ann Oncol. 2011 Mar;22(3):636-642. doi: 10.1093/annonc/mdq401. Epub 2010 Aug 9. Ann Oncol. 2011. PMID: 20696677 Free article. Clinical Trial.
Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.
Nagase S, Katabuchi H, Hiura M, Sakuragi N, Aoki Y, Kigawa J, Saito T, Hachisuga T, Ito K, Uno T, Katsumata N, Komiyama S, Susumu N, Emoto M, Kobayashi H, Metoki H, Konishi I, Ochiai K, Mikami M, Sugiyama T, Mukai M, Sagae S, Hoshiai H, Aoki D, Ohmichi M, Yoshikawa H, Iwasaka T, Udagawa Y, Yaegashi N; Japan Society of Gynecologic Oncology. Nagase S, et al. Among authors: yaegashi n. Int J Clin Oncol. 2010 Dec;15(6):531-42. doi: 10.1007/s10147-010-0138-6. Epub 2010 Nov 11. Int J Clin Oncol. 2010. PMID: 21069552
Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma.
Hayashi T, Horiuchi A, Sano K, Hiraoka N, Kasai M, Ichimura T, Nagase S, Ishiko O, Shiozawa T, Kanai Y, Yaegashi N, Aburatani H, Tonegawa S, Konishi I. Hayashi T, et al. Among authors: yaegashi n. N Am J Med Sci. 2011 Sep;3(9):394-9. doi: 10.4297/najms.2011.3394. N Am J Med Sci. 2011. PMID: 22362447 Free PMC article.
Potential role of LMP2 as an anti-oncogenic factor in human uterine leiomyosarcoma: morphological significance of calponin h1.
Hayashi T, Horiuchi A, Sano K, Hiraoka N, Kasai M, Ichimura T, Sudo T, Nishimura R, Ishiko O, Shiozawa T, Kanai Y, Yaegashi N, Aburatani H, Konishi I. Hayashi T, et al. Among authors: yaegashi n. FEBS Lett. 2012 Jun 21;586(13):1824-31. doi: 10.1016/j.febslet.2012.05.029. Epub 2012 May 29. FEBS Lett. 2012. PMID: 22659265 Free article.
Potential biomarker for human uterine leiomyosarcoma.
Hayashi T, Horiuchi A, Aburatani H, Ishiko O, Yaegashi N, Kanai Y, Zharhary D, Shiozawa T, Tonegawa S, Konishi I. Hayashi T, et al. Among authors: yaegashi n. J Clin Med Res. 2014 Oct;6(5):392-4. doi: 10.14740/jocmr1867e. Epub 2014 Jul 28. J Clin Med Res. 2014. PMID: 25110546 Free PMC article. No abstract available.
850 results